Delivery Order SPE2DB20D3101-SPE2DB23FRXP9
Award Date 9/14/23
Potential Completion Date 9/15/23
Potential Value $45
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $44,630 to Amerisourcebergen Drug Corporation for ketorolac injection vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period in September 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order is likely associated with DLA's procurement of medical materiel in support of the agency's logistics operations...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injectable solution. This firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program, through which DLA provides pharmaceuticals and medical supplies to various Department of Defense entities. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. No subcontractors or set...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately ninety-five thousand dollars to Amerisourcebergen Drug Corporation for ketorolac injection vials. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a two day period in late September 2023. No subcontractors or set aside designations were indicated. This order is likely placed against DLA's Pharmaceutical Prime Vendor contract, which provides pharmaceuticals and...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. The firm fixed price order is being fulfilled under the Prime Vendor Pharmaceutical program and will provide 30mg/mL ketorolac vials to support DLA needs. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a four day period concluding on September 19, 2023. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac 30 mg/ml vials. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between September 5-6, 2023. The DLA manages the Department of Defense's global logistics operations and supply chain, procuring medical and pharmaceutical supplies to support military treatment facilities. No subcontractors or set aside designations were indicated. The...
- The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac 30 mg/ml vials. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle to supply pharmaceutical products and services to DLA and DoD customers. Performance will take place at Amerisourcebergen's distribution facility in Conshohocken, Pennsylvania over a period of one day, from September 14 to 15, 2023. No set aside designation or...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $391 to Amerisourcebergen Drug Corporation to provide ketorolac injection vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical to its place of performance in Conshohocken, Pennsylvania by August 1, 2023 in support of DLA requirements. No subcontractors or set aside designations were indicated. This order is consistent with DLA's mission to provide medical supplies and...
- The Defense Logistics Agency awarded a $187,740 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. The one-day contract has a period of performance from September 14 to 15, 2023 for delivery to a location in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a nonsteroidal anti-inflammatory drug supports the Agency's mission to provide critical medicines...
- The Defense Logistics Agency awarded a $133,890 delivery order to Amerisourcebergen Drug Corporation for ketorolac 30 mg/ml vials. The firm fixed price order is for product delivery to a location in Conshohocken, Pennsylvania between August 27-28, 2023. The DLA manages the Department of Defense's global logistics operations and supply chain network. This small order for a non-narcotic pain medication is likely in support of treatment for service members and is a routine replenishment under one...
- The Defense Logistics Agency awarded a $12,780 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. The one-day contract has a period of performance from September 25-26, 2023 for product delivery. Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The brief contract aligns with the...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRXP9Delivery Order
The Defense Logistics Agency awarded a $44,630 delivery order to Amerisourcebergen Drug Corporation for ketorolac injection vials. This firm fixed price order is being fulfilled under the prime contractor's corporate office division in Conshohocken, Pennsylvania, with all products required to be delivered between September 14-15, 2023. The DLA facilitates procurement across the Department of Defense enterprise and supports military treatment facilities, so this order is likely supplying needed pharmaceuticals to DOD medical treatment locations. No subcontractors or set aside designations were specified.
Generated 12/23/23, 3:11 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $45 | 9/14/23 |